title: MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients.
abstract: Tyrosinemia type-I results from lack of fumarylacetoacetate hydrolase (FAH), which is a liver enzyme and also shown to be present in lymphocytes, fibroblasts, and cultured amniotic fluid cells. In young infants, symptoms of untreated Tyrosinemia type-I are restricted to severe liver involvement. Later in the first year; however, it is known to be present with liver and renal tubular dysfunction associated with growth failure and rickets. MicroRNAs are small regulatory RNAs that function post-transcriptionally. They target commonly 3'-UTR of the mRNAs and inhibit protein expression by either blocking the synthesis or causing degradation of the mRNAs. MiRNA deregulation was observed in a variety of pathologic conditions but their roles in metabolic diseases were remained unsolved. We studied 6 patients with classical phenotypes of Tyrosinemia type-I. To identify possible miRNAs targeting FAH transcripts, microarray profiling of 961 miRNAs for lymphocytes and serum is performed. Computational algorithms are used for prediction of putative mRNA-miRNA interactions. A number of deregulated miRNAs, targeting the non-conserved sites on FAH transcripts were found. Besides, there are some miRNAs that are similarly altered both in lymphocytes and serum, possibly contributing to the disease phenotype. Since miRNAs may have an active role in the enzymatic pathway of tyrosine catabolism, characterizing miRNA profile in fibroblasts of tyrosinemia patients is also important because miRNAs would have distinctive role in disease pathogenesis and they are promising for future therapeutic studies.
authors: Department of Medical Genetics, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
authors: Omer Faruk
authors: OF
authors: Karatas
authors: Esra
authors: E
authors: Guzel
authors: Ender
authors: E
authors: Karaca
authors: Serhat
authors: S
authors: Sevli
authors: Erdogan
authors: E
authors: Soyucen
authors: Adnan
authors: A
authors: Yuksel
authors: Mustafa
authors: M
authors: Ozen
mesh_terms: D002648:Child; D002675:Child, Preschool; D016000:Cluster Analysis; D019295:Computational Biology; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism*; D035683:MicroRNAs / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020176:Tyrosinemias / Q000097:blood / Q000235:genetics*
chemical_list: D035683:MicroRNAs; D012333:RNA, Messenger
references: Prostate Cancer Prostatic Dis. 2010 Sep;13(3):208-17
references: 20585343
references: Pediatr Res. 1983 Jul;17(7):541-4
references: 6622096
references: Epigenomics. 2010 Oct;2(5):697-708
references: 22122053
references: Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6
references: 16602095
references: J Pediatr. 1965 Apr;66:670-96
references: 14271358
references: Oncogene. 2008 Mar 13;27(12):1788-93
references: 17891175
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D691-7
references: 21067998
references: PLoS One. 2011;6(6):e20980
references: 21738599
references: N Engl J Med. 2010 Mar 25;362(12):1102-9
references: 20335586
references: Cell. 2005 Jan 14;120(1):15-20
references: 15652477
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D105-10
references: 18996891
references: Nat Genet. 2011 Mar;43(3):259-63
references: 21278747
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D619-22
references: 18981052
references: Nature. 2005 Jun 9;435(7043):834-8
references: 15944708
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D561-8
references: 21045058